Predictors affecting durability of epicardial pacemaker leads in pediatric patients

被引:33
作者
Murayama, Hiroomi [1 ]
Maeda, Masanobu [1 ]
Sakurai, Hajime [1 ]
Usui, Akihiko [2 ]
Ueda, Yuichi [2 ]
机构
[1] Nagoya Univ, Social Insurance Chukyo Hosp, Dept Cardiovasc Surg, Nagoya, Aichi, Japan
[2] Nagoya Univ, Dept Cardiothorac Surg, Nagoya, Aichi, Japan
关键词
D O I
10.1016/j.jtcvs.2007.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Despite pacemaker therapy in children and adolescents favoring an initial epicardial approach, predictors of lead failure have not been well clarified. The aim of this study was to assess the long-term outcomes and to determine predictors affecting lead durability in pediatric pacing therapy. Methods: We reviewed the outcomes of 109 consecutive pacing leads implanted in 55 patients (median age, 5.2 years; range, 31 days -15.8 years), including 38 atrial and 71 ventricular leads. They consisted of 58 (53%) fishhooks, 37 (34%) screw-in leads, and 14 (13%) steroid-eluting suture-on leads. Seventy (64%) were implanted in patients with structural heart disease. Results: The leads were followed for a median of 6.4 years (range, 3 days -22.9 years). Lead failure occurred in 29 leads (27%; median of 8.4 years after implantation). Exit block or elevation of pacing threshold was the most common cause (n = 18), but failures did not directly cause patient death. The overall 1-, 5-, 10-, and 15-year lead survivals were 100%, 89.0%, 72.5%, and 55.5%, respectively. Multivariate Cox analysis revealed concurrent structural heart disease (relative risk, 2.85; 95% confidence interval, 1.27 -6.42; P =.011) to be the only significant predictor of lead failure. Conclusions: Epicardial leads provide a reliable technique for managing rhythmic disturbance problems in the pediatric population. The only significant predictor of lead failure is the presence of structural heart disease.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 22 条
[1]  
Ayabakan Canan, 2006, Indian Pacing Electrophysiol J, V6, P57
[2]  
Beaufort-Krol GCM, 1999, J THORAC CARDIOV SUR, V117, P523
[3]   Precipitous exit block with epicardial steroid-eluting leads [J].
Beder, SD ;
Kuehl, KS ;
Hopkins, RA ;
Tonder, LM ;
Mans, DR .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (12) :2954-2957
[4]   Epicardial pacemaker implantation and follow-up in patients with a single ventricle after the Fontan operation [J].
Cohen, MI ;
Vetter, VL ;
Wernovsky, G ;
Bush, DM ;
Gaynor, JW ;
Iyer, VR ;
Spray, TL ;
Tanel, RE ;
Rhodes, LA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (04) :804-811
[5]  
Cohen MI, 2001, CIRCULATION, V103, P2585
[6]  
DELEON SY, 1990, J THORAC CARDIOV SUR, V99, P905
[7]   Risk factors for venous obstruction in children with transvenous pacing leads [J].
Figa, FH ;
McCrindle, BW ;
Bigras, JL ;
Hamilton, RM ;
Gow, RM .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (08) :1902-1909
[8]   TRANSVENOUS PACING IN PEDIATRIC-PATIENTS [J].
GILLETTE, PC ;
SHANNON, C ;
BLAIR, H ;
PORTER, CJ ;
MCNAMARA, DG ;
GARSON, A .
AMERICAN HEART JOURNAL, 1983, 105 (05) :843-847
[9]   Chronic performance of steroid-eluting epicardial leads in a growing pediatric population: A 10-year comparison [J].
Horenstein, MS ;
Hakimi, M ;
Walters, H ;
Karpawich, PP .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (07) :1467-1471
[10]   Transesophageal echocardiography in the diagnosis of thrombosis associated with permanent transvenous pacemaker electrodes [J].
Korkeila, Petri J. ;
Saraste, Markku K. ;
Nyman, Kai M. ;
Koistinen, Juhani ;
Lund, Juha ;
Airaksinen, Karl Eino Juhani .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (11) :1245-1250